LETTER TO STAKEHOLDERS REGARDING THE REQUIREMENTS TO PROVIDE RESULTS FOR AUTHORISED CLINICAL TRIALS IN EUDRACT

Joint Letter by the European Commission, EMA and HMA PDF, 220KB, Datei ist nicht barrierefrei